RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Compounds having unique CB1 receptor binding selectivity and methods for their production and use

Thomas, B., Seltzman, H., & Francisco, MY. (2004). Compounds having unique CB1 receptor binding selectivity and methods for their production and use. (U.S. Patent No. 6825209). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6825209

Abstract

Compounds are provided that are amide analogs of SR141716A having unique CB1 receptor selectivity and providing WIN sparing binding characteristics, pharmaceutical compositions containing the compounds and their use in a method of treatment of CB1 receptor related disorders, such as obesity, schizophrenia, memory dysfunction and marijuana abuse.

Download/Explore
Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.